- Home
- ECOR vs PEPG Comparison
ECOR vs PEPG Comparison
Compare ECOR & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- PEPG
- Stock Information
- Founded
- ECOR 2005
- PEPG 2018
- Country
- ECOR United States
- PEPG United States
- Employees
- ECOR N/A
- PEPG N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- ECOR Health Care
- PEPG Health Care
- Exchange
- ECOR Nasdaq
- PEPG Nasdaq
- Market Cap
- ECOR 111.3M
- PEPG 118.3M
- IPO Year
- ECOR 2018
- PEPG 2022
- Fundamental
- Price
- ECOR $15.90
- PEPG $2.30
- Analyst Decision
- ECOR Strong Buy
- PEPG Buy
- Analyst Count
- ECOR 1
- PEPG 3
- Target Price
- ECOR $25.00
- PEPG $14.67
- AVG Volume (30 Days)
- ECOR 144.8K
- PEPG 187.3K
- Earning Date
- ECOR 03-12-2025
- PEPG 03-05-2025
- Dividend Yield
- ECOR N/A
- PEPG N/A
- EPS Growth
- ECOR N/A
- PEPG N/A
- EPS
- ECOR N/A
- PEPG N/A
- Revenue
- ECOR $23,327,000.00
- PEPG N/A
- Revenue This Year
- ECOR $59.81
- PEPG N/A
- Revenue Next Year
- ECOR $38.49
- PEPG N/A
- P/E Ratio
- ECOR N/A
- PEPG N/A
- Revenue Growth
- ECOR 74.10
- PEPG N/A
- 52 Week Low
- ECOR $5.32
- PEPG $2.30
- 52 Week High
- ECOR $18.67
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- ECOR 53.73
- PEPG 20.33
- Support Level
- ECOR $15.50
- PEPG $3.69
- Resistance Level
- ECOR $16.12
- PEPG $4.48
- Average True Range (ATR)
- ECOR 1.20
- PEPG 0.30
- MACD
- ECOR -0.31
- PEPG -0.08
- Stochastic Oscillator
- ECOR 40.17
- PEPG 0.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.